18-60183864-T-C

Variant names:

• chr18-60183864-T-C
• rs17782313

GermlineCancer (beta)

Variant summary

Our verdict is Likely benign.

-4 Likely Benign

-7

-6

-1

0

+5

+6

+9

+10

BenignB

Likely BenignLB

UncertainVUS

Likely PathogenicLP

PathogenicP

The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The variant 18-60183864-T-C has been identified. The variant allele was found at a cumulative frequency of 0.237 (AC=36,110) in the gnomAD database across 152,140 control chromosomes, including 4,475 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.337. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.24 (4475 hom., cov: 32)
• Consequence: Unknown
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.757
• Publications: 681 publications found

Classification according to ACGS-UK Somatic Oncogenicity v2025

Our verdict: Likely_benign. The variant received -4 points.

Apply	Criterion Code & Title / Strength	Strength	Rationale / Clinical Context
	B1High frequency in general population		GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.337 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

 

RefSeq Transcripts

There are no transcript annotations for this variant.

Ensembl Transcripts

There are no transcript annotations for this variant.

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)

Rare (AF ≤ 0.0001 / Hom ≤ 1)

Source / population	AF	AC	Hom	AN	Coverage
Global population databases 4 sources Large-scale international reference populations
GnomAD3 genomes	AF: 0.237	AC:36072	Hom:4474	AN:152022	Cov:32
GnomAD4 genome	AF: 0.237	AC:36110	Hom:4475	AN:152140	Cov:32
TOPMed (Bravo)	AF: 0.236	AC:62552	Hom:7746	AN:264690	Cov:
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)	AF: 0.234	AC:159807	Hom:19052	AN:681812	Cov:
Local & regional cohorts 10 sources Population-specific and national genomic databases
ABraOM SABE-WGS-1171	AF: 0.194	AC:455	Hom:47	AN:2342	Cov:
ChinaMAP Phase 1	AF: 0.201	AC:	Hom:	AN:	Cov:
Denmark Genome	AF: 0.233	AC:70	Hom:	AN:300	Cov:
GenomeAsia100K	AF: 0.226	AC:787	Hom:	AN:3478	Cov:
Korea4K (4,157 Koreans)	AF: 0.255	AC:1842	Hom:	AN:7234	Cov:
Qatari Genome	AF: 0.290	AC:51	Hom:	AN:176	Cov:
ToMMo 61KJPN (+60KJPN MNV)	AF: 0.227	AC:27918	Hom:3155	AN:122776	Cov:
Turkish Variome	AF: 0.314	AC:486	Hom:72	AN:1546	Cov:
UK10K	AF: 0.233	AC:1762	Hom:	AN:7562	Cov:
WBBC (Westlake BioBank for Chinese) pilot	AF: 0.180	AC:1611	Hom:135	AN:8960	Cov:

Showing 14 sources

Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

Algorithm	Calibrated pred.	Score	Prediction
AlphaGenome AVI	Benign	1.2
BayesDel_noAF	Benign	-0.89
CADD	Benign	3.2
DANN	Benign	0.73
GPN-Star LLR	N/A	0.15
GPN-Star score	N/A	-0.15
PhyloP100	Benign	0.76

Showing 7 of 7 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Other links and lift over

dbSNP: rs17782313;

hg19: chr18-57851097;

ACMG debug oncogenicity

ACGS debug oncogenicity

ACMG debug germline

Submit to ClinVar